Maruki, Y.; Morizane, C.; Okada, M.; Harai, S.; Nagashio, Y.; Hijioka, S.; Ueno, H.; Okusaka, T.
First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice. Int. J. Mol. Sci. 2025, 26, 5586.
https://doi.org/10.3390/ijms26125586
AMA Style
Maruki Y, Morizane C, Okada M, Harai S, Nagashio Y, Hijioka S, Ueno H, Okusaka T.
First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice. International Journal of Molecular Sciences. 2025; 26(12):5586.
https://doi.org/10.3390/ijms26125586
Chicago/Turabian Style
Maruki, Yuta, Chigusa Morizane, Mao Okada, Shota Harai, Yoshikuni Nagashio, Susumu Hijioka, Hideki Ueno, and Takuji Okusaka.
2025. "First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice" International Journal of Molecular Sciences 26, no. 12: 5586.
https://doi.org/10.3390/ijms26125586
APA Style
Maruki, Y., Morizane, C., Okada, M., Harai, S., Nagashio, Y., Hijioka, S., Ueno, H., & Okusaka, T.
(2025). First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice. International Journal of Molecular Sciences, 26(12), 5586.
https://doi.org/10.3390/ijms26125586
